These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 26932781

  • 1. Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention.
    Yu S, Yan C, Yang X, He S, Liu J, Qin C, Huang C, Lu Y, Tian Z, Jia L.
    Sci Rep; 2016 Mar 02; 6():22388. PubMed ID: 26932781
    [Abstract] [Full Text] [Related]

  • 2. Metapristone (RU486 derivative) inhibits cell proliferation and migration as melanoma metastatic chemopreventive agent.
    Zheng N, Chen J, Liu W, Wang J, Liu J, Jia L.
    Biomed Pharmacother; 2017 Jun 02; 90():339-349. PubMed ID: 28376402
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, Jiang H, Ren J, Cai J, Li Q.
    BMC Cancer; 2015 Mar 05; 15():97. PubMed ID: 25884904
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X, Yan W, Dai Z, Gao X, Ma Y, Xu Q, Jiang J, Zhang S.
    Drug Des Devel Ther; 2016 Mar 05; 10():1419-41. PubMed ID: 27143851
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
    Tian L, Shen D, Li X, Shan X, Wang X, Yan Q, Liu J.
    Oncotarget; 2016 Jan 12; 7(2):1619-32. PubMed ID: 26636541
    [Abstract] [Full Text] [Related]

  • 14. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ, Choi WI, Jeon BN, Choi KC, Kim K, Kim TJ, Ham J, Jang HJ, Kang KS, Ko H.
    Toxicology; 2014 Aug 01; 322():23-33. PubMed ID: 24793912
    [Abstract] [Full Text] [Related]

  • 15. A novel co-drug of aspirin and ursolic acid interrupts adhesion, invasion and migration of cancer cells to vascular endothelium via regulating EMT and EGFR-mediated signaling pathways: multiple targets for cancer metastasis prevention and treatment.
    Tang Q, Liu Y, Li T, Yang X, Zheng G, Chen H, Jia L, Shao J.
    Oncotarget; 2016 Nov 08; 7(45):73114-73129. PubMed ID: 27683033
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.
    Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, Kawaguchi Y, Fujimoto K, Hosotani R, Imamura M.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4125-33. PubMed ID: 15217949
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
    Sun XD, Liu XE, Huang DS.
    Oncol Rep; 2013 Jun 15; 29(6):2401-7. PubMed ID: 23563640
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.